Stopping lamivudine therapy after biochemical breakthrough may be a feasible option in selected HBeAg-positive patients

Jeong Won Jang, Jong Young Choi, Si Hyun Bae, Seung Kew Yoon, Chang Wook Kim, Soon Woo Nam, Chang Don Lee, Young Sok Lee, Sang Bok Cha, Kyu Won Chung

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Stopping lamivudine therapy after biochemical breakthrough may be a feasible option in selected HBeAg-positive patients'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology